TNFSF11 and rheumatoid arthritis: A recent study has shown that RANKL serum concentrations are highest in RA associated with periodontal disease (PD) and that a denosumab treatment suppresses the progression of RA in a randomized controlled trial (Panezai et al., 2018; Tanaka and Tanaka, 2021).